Podcasts about mitral

Two heart surgeons looked at the same heart and gave me opposite advice. One said plan surgery. The other said wait.At 42, in the best shape of my life, I was diagnosed with mitral valve prolapse with severe regurgitation. And suddenly I had to answer a question I never expected to face:

I never thought heart disease would be part of my story. At 42, in the best shape of my life, I was diagnosed with mitral valve prolapse and severe regurgitation. What started as a strange episode during a workout turned into months of fear, waiting, uncertainty, and eventually heart surgery. This is Part 1 of My Heart Story. In this episode of Anatomy of a Leader, I share what it was really like to be diagnosed with a heart condition at 42 — from early symptoms and medical tests to the emotional impact of living with uncertainty while raising young children and running a business. This is the beginning of a deeper series about fear, vulnerability, healing, and what happens when your body forces you to slow down and listen.This is not medical advice. This is my real story — shared in the hope that it helps someone feel less alone, recognise symptoms earlier, or feel brave enough to get checked.In this episode I talk about: – Mitral valve prolapse diagnosis – Heart palpitations and symptoms – ECG and echocardiogram experience – Waiting for cardiology appointments – Anxiety and fear after diagnosis – Exercising with a heart condition – Women's heart health being underdiagnosed – Why “being strong” can make illness lonelier00:00 Thought Heart Disease Was an Old Man's Problem00:51 I Was Physically Fit & Healthy01:20 The Workout That Changed Everything01:56 Why I Nearly Ignored The Symptoms03:14 Going To The GP03:45 ECG Referral & Experience06:11 Echo Referral & Experience 09:03 Hearing “Mitral Valve Prolapse”09:50 Waiting, Fear & Not Knowing13:00 Anxiety vs Heart Condition13:23 Tachycardia, A&E & Health System14:21 Symptoms of Mitral Valve Prolapse 16:12 Exercise Regularly & Monitor17:49 Exercising With A Heart Condition18:39 Loss Of Control & Trust20:38 Women's Heart Health Being Missed23:10 What I Wish I'd Known25:15 If You're Ignoring Symptoms — Please ListenFollow Maria Hvorostovsky:IG: https://www.instagram.com/anatomyofaleader/IG: https://www.instagram.com/mariahvorostovsky/LinkedIn: https://www.linkedin.com/in/mariahvo/TikTok: https://www.tiktok.com/@mariahvorostovsky/Website: https://www.anatomyofaleader.com/Artwork and video by https://www.londonbeautyphotographer.com/If you're living with a heart condition, supporting someone who is, or ignoring symptoms because life feels too busy — this episode is for you.

No Click Valvar de hoje temos grandes insights sobre qual a pior complicação em casos de clipagem mitral. 

Join Digital Education Committee Chair and podcast host Michael S. Lloyd, MD, FHRS, and his guests Kelvin C. Chua, MBBS, MD, FHRS, CEPS-A, and Rahul N Doshi, MD, FHRS, for this week's Lead episode, which was recorded live at APHRS 2025 in Kyoto, Japan. This discussion will review recent evidence on the feasibility and safety of pulsed field ablation (PFA) for coronary sinus and left atrial appendage isolation, as well as mitral isthmus ablation, focusing on both acute and chronic outcomes. Panelists will examine procedural considerations, lesion durability, and safety signals highlighted in the study, and explore how these findings may inform evolving ablation strategies for complex atrial arrhythmias.   Learning Objectives Summarize the acute and chronic feasibility and safety outcomes of pulsed field ablation (PFA) for coronary sinus isolation, left atrial appendage isolation, and mitral isthmus ablation as reported in the study. Evaluate procedural techniques and lesion durability considerations associated with using PFA in anatomically complex atrial structures. Assess the potential clinical implications of these findings for incorporating PFA into ablation strategies for complex atrial arrhythmias, including patient selection and risk mitigation.   Podcast Contributors Michael S. Lloyd, MD, FHRS Kelvin C. Chua, MBBS, MD, FHRS, CEPS-A Rahul N Doshi, MD, FHRS   Host and Contributor Disclosure(s): K.C. Chua•Nothing to disclose. R. N. Doshi•Speaking/Teaching/Consulting/Authoring: Boston Scientific, Kestra Inc., Abbott, Impulse Dynamics USA    M. S. Lloyd •Honoraria/Speaking/Consulting: Medtronic, Agra MedTech, Circa Scientific •Membership on Advisory Committees: Boston Scientific   Article for Discussion

Commentary by Dr.  Jian'an Wang.

Read the article here: https://journals.sagepub.com/doi/full/10.1177/30494826251393909

Read the article here: https://journals.sagepub.com/doi/full/10.1177/30494826251396933

No Click Valvar Academy de hoje temos grandes insights sobre os resultados atuais do valve-in-valve mitral.

Interview with Ankur Kalra, MD

No Click Valvar Academy de hoje temos grandes insights sobre o uso do strain em regurgitação mitral primária. Ficou demais!

Case Discussion 124: Anticoagulation in Patients with Mitral Stenosis

Send us a textNeste episódio, entramos fundo no universo do ecocardiograma aplicado às doenças da valva mitral, um tema que mexe diretamente com decisões no consultório, na enfermaria e na UTI. Conversamos sobre como diferenciar regurgitação mitral primária de secundária pelo laudo, quais pistas estruturais realmente importam e como o clínico pode interpretar o mecanismo da lesão de forma prática. E claro, discutimos uma dúvida clássica do dia a dia: dá para diferenciar vegetação de trombo só pelo eco? A imagem ajuda muito, mas nunca trabalha sozinha. Exploramos ainda: • Quando o ECO-TE realmente muda a condução; • O papel do ECO 3D na avaliação da mitral e no planejamento de intervenções; • Por que a avaliação quantitativa da IM precisa ir além de apenas olhar o jato; • Quais parâmetros objetivos definem a gravidade da IM;• A pegadinha da FEVE aparentemente boa na IM crônica;• Como o status hemodinâmico pode transformar completamente o grau da IM; • O melhor método para medir área valvar na estenose mitral; • Como calcular e interpretar o escore de Wilkins; • Quando pedir ECO-TE na estenose mitral; • Em quais situações considerar MitraClip; Um episódio completo, didático e direto ao ponto, ideal para clínicos, cardiologistas e residentes que querem interpretar o ecocardiograma da valva mitral com mais segurança, clareza e profundidade.

This week we review the topic of mitral annular disjunction ("MAD") and the possible association with ventricular arrhythmia or sudden death in the connective tissue disease patient. Is there a 'cut off' distance above which patients deserve more significant arrhythmia surveillance? What is the best way to measure the MAD distance? Can patients with low MAD distances have lower degrees or even no arrhythmic surveillance? How often should this distance be measured on CMR and can an echo measurement provide similar data? Dr. Daniel Castellanos, the first author of this work and Assistant Professor of Pediatrics at Harvard Medical School shares his deep insights this week.DOI: 10.1016/j.jocmr.2025.101954

Read the article here: https://journals.sagepub.com/doi/full/10.1177/30494826251362814

Read the article here: https://journals.sagepub.com/doi/full/10.1177/30494826251344846

Read the article here: https://journals.sagepub.com/doi/full/10.1177/30494826251347539

Read the article here: https://journals.sagepub.com/doi/full/10.1177/30494826241313425

Insuficiência mitral pós-IAM: diferenciar ruptura de tethering é vital by Cardiopapers

No Click Valvar Academy de hoje temos grandes insights sobre o impacto da internação hospitalar no momento ideal de efetuar uma clipagem mitral.

A new era for complex mitral regurgitation. The ENCIRCLE pivotal trial in The Lancet reports that fully percutaneous, transfemoral, transseptal TMVR (SAPIEN M3) achieved durable MR reduction (≈96% ≤1+ at 1 year), low early mortality, and meaningful improvement in symptoms and quality of life for patients unsuitable for surgery or TEER.   A third pathway for mitral disease is emerging—one built on precision access, valve-in-valve durability planning, and advancing patient selection.   Innovation meeting clinical need.

No Click Valvar Academy de hoje temos grandes insights sobre os aspectos anatômicos da valva mitral na Cardiopatia Reumática. Está demais!

A nova Diretriz de Valvopatias da ESC 2025 chegou e consolidou uma virada histórica: as abordagens transcateter finalmente ganharam protagonismo.No episódio #198 do DozeCast, Mateus Prata e Diandro Mota recebem o Dr. Vitor Emer para revisar de forma crítica e prática o que muda na conduta das valvopatias mais prevalentes — e o que você precisa ajustar na sua tomada de decisão.

Send us a textCheck our the full viva in the Final Exam Coursehttps://anaesthesia.thinkific.com/courses/FinalExam---------Find us atInstagram: https://www.instagram.com/abcsofanaesthesia/Twitter: https://twitter.com/abcsofaWebsite: http://www.anaesthesiacollective.comPodcast: ABCs of AnaesthesiaPrimary Exam Podcast: Anaesthesia Coffee BreakFacebook Page: https://www.facebook.com/ABCsofAnaesthesiaFacebook Private Group: https://www.facebook.com/groups/2082807131964430---------Check out all of our online courses and zoom teaching sessions here!https://anaesthesia.thinkific.com/collectionshttps://www.anaesthesiacollective.com/courses/---------#Anesthesiology #Anesthesia #Anaesthetics #Anaesthetists #Residency #MedicalSchool #FOAMed #Nurse #Medical #Meded ---------Please support me at my patreonhttps://www.patreon.com/ABCsofA---------Any questions please email abcsofanaesthesia@gmail.com---------Disclaimer: The information contained in this video/audio/graphic is for medical practitioner education only. It is not and will not be relevant for the general public.Where applicable patients have given written informed consent to the use of their images in video/photography and aware that it will be published online and visible by medical practitioners and the general public.This contains general information about medical conditions and treatments. The information is not advice and should not be treated as such. The medical information is provided “as is” without any representations or warranties, express or implied. The presenter makes no representations or warranties in relation to the medical information on this video. You must not rely on the information as an alternative to assessing and managing your patient with your treating team and consultant. You should seek your own advice from your medical practitioner in relation to any of the topics discussed in this episode' Medical information can change rapidly, and the author/s make all reasonable attempts to provide accurate information at the time of filming. There is no guarantee that the information will be accurate at the time of viewingThe information provided is within the scope of a specialist anaesthetist (FANZCA) working in Australia.The information presented here does not represent the views of any hospital or ANZCA.These videos are solely for training and education of medical practitioners, and are not an advertisement. They were not sponsored and offer no discounts, gifts or other inducements. This disclaimer was created based on a Contractology template available at http://www.contractology.com.

We've got a three-peat favorite back on the mic—Dr. Karl Jandrey, DVM, DACVECC, emergency & critical care specialist at UC Davis School of Veterinary Medicine. In this “Ask the Vet” deep dive, Dr. Jandrey breaks down how heart disease shows up in pets, what to watch for at home, and what your vet does first in the ER.You'll learn the stealth early signs in dogs (like true exercise intolerance vs. stubbornness), when coughing and increased breathing effort mean “go now,” and why small breeds often face mitral valve disease while large breeds are at risk for dilated cardiomyopathy (including the grain-free/taurine connection). We also cover arrhythmias (like AFib) and dramatic collapses, the core ER toolkit (oxygen, ultrasound, diuretics), and practical home monitoring (why ≤30 breaths/min at rest matters).For cats, Dr. Jandrey explains hypertrophic cardiomyopathy (HCM)—why it's so hard to spot, the realities of sudden distress or clots (ATE), and what treatment and prognosis can look like. Plus: a quick detour into exciting oncology advances (hello, Lola the Golden Retriever!) and a feel-good moment with Dr. Jandrey's lab, Danson, a veteran blood donor.Send us your questions for a future Ask the Vet!Highlights / What You'll Learn:- Early, often-missed signs of cardiac disease in dogs- Mitral valve disease vs. dilated cardiomyopathy—who's at risk and why- ER playbook: oxygen, Lasix (furosemide), rhythm control, point-of-care ultrasound- Home check: how to count resting respiratory rate and what numbers matter- Cats & HCM: silent disease, clots, emergency steps, and tough decisions- Meds 101: pimobendan, digoxin, diuretics—where they fit- Diet note: taurine and the grain-free discussionWe also briefly discuss:pet heart disease, dog coughing heart, resting respiratory rate dog, dilated cardiomyopathy dogs, mitral valve disease small dogs, hypertrophic cardiomyopathy cats, cat blood clot back legs, veterinary ER, pimobendan for dogs, taurine deficiency grain-freehttps://www.vetmed.ucdavis.edu/faculty/karl-e-jandrey--What started during the COVID-19 lockdown with one baby gorilla at the Cleveland Zoo has grown into a channel loved by animal fans around the world. I'm a one-person operation—filming, editing, narrating, and sharing the most heartfelt moments of baby gorillas, orangutans, elephants, and other zoo animals. Whether it's Jameela's emotional journey or Clementine's first steps, each video brings you closer to the animals and their stories. If you love watching real animal behavior, learning fun facts, and supporting conservation through storytelling—this is your place! Subscribe to Larry's Animal Safari on YouTube @larrysanimalsafari ---Support our sponsor for this episode Blue Buffalo by visiting bluebuffalo.com. BLUE Natural Veterinary Diet formulas offer the natural alternative in nutritional therapy. At Blue Buffalo, we have an in-house Research & Development (R&D) team with over 300 years' experience in well-pet and veterinary therapeutic diets, over 600 scientific publications, and over 50 U.S. patents. At Blue Buffalo, we have an in-house Research & Development (R&D) team with over 300 years' experience in well-pet and veterinary therapeutic diets, over 600 scientific publications, and over 50 U.S. patents.---All footage is owned by SLA Video Productions.

We've got a three-peat favorite back on the mic—Dr. Karl Jandrey, DVM, DACVECC, emergency & critical care specialist at UC Davis School of Veterinary Medicine. In this “Ask the Vet” deep dive, Dr. Jandrey breaks down how heart disease shows up in pets, what to watch for at home, and what your vet does first in the ER.You'll learn the stealth early signs in dogs (like true exercise intolerance vs. stubbornness), when coughing and increased breathing effort mean “go now,” and why small breeds often face mitral valve disease while large breeds are at risk for dilated cardiomyopathy (including the grain-free/taurine connection). We also cover arrhythmias (like AFib) and dramatic collapses, the core ER toolkit (oxygen, ultrasound, diuretics), and practical home monitoring (why ≤30 breaths/min at rest matters).For cats, Dr. Jandrey explains hypertrophic cardiomyopathy (HCM)—why it's so hard to spot, the realities of sudden distress or clots (ATE), and what treatment and prognosis can look like. Plus: a quick detour into exciting oncology advances (hello, Lola the Golden Retriever!) and a feel-good moment with Dr. Jandrey's lab, Danson, a veteran blood donor.Send us your questions for a future Ask the Vet!Highlights / What You'll Learn:- Early, often-missed signs of cardiac disease in dogs- Mitral valve disease vs. dilated cardiomyopathy—who's at risk and why- ER playbook: oxygen, Lasix (furosemide), rhythm control, point-of-care ultrasound- Home check: how to count resting respiratory rate and what numbers matter- Cats & HCM: silent disease, clots, emergency steps, and tough decisions- Meds 101: pimobendan, digoxin, diuretics—where they fit- Diet note: taurine and the grain-free discussionWe also briefly discuss:pet heart disease, dog coughing heart, resting respiratory rate dog, dilated cardiomyopathy dogs, mitral valve disease small dogs, hypertrophic cardiomyopathy cats, cat blood clot back legs, veterinary ER, pimobendan for dogs, taurine deficiency grain-freehttps://www.vetmed.ucdavis.edu/faculty/karl-e-jandrey--What started during the COVID-19 lockdown with one baby gorilla at the Cleveland Zoo has grown into a channel loved by animal fans around the world. I'm a one-person operation—filming, editing, narrating, and sharing the most heartfelt moments of baby gorillas, orangutans, elephants, and other zoo animals. Whether it's Jameela's emotional journey or Clementine's first steps, each video brings you closer to the animals and their stories. If you love watching real animal behavior, learning fun facts, and supporting conservation through storytelling—this is your place! Subscribe to Larry's Animal Safari on YouTube @larrysanimalsafari ---Support our sponsor for this episode Blue Buffalo by visiting bluebuffalo.com. BLUE Natural Veterinary Diet formulas offer the natural alternative in nutritional therapy. At Blue Buffalo, we have an in-house Research & Development (R&D) team with over 300 years' experience in well-pet and veterinary therapeutic diets, over 600 scientific publications, and over 50 U.S. patents. At Blue Buffalo, we have an in-house Research & Development (R&D) team with over 300 years' experience in well-pet and veterinary therapeutic diets, over 600 scientific publications, and over 50 U.S. patents.---All footage is owned by SLA Video Productions.

Commentary by Dr. Jian'an Wang.

Commentary by Dr. Jian'an Wang.

Commentary by Dr.  Jian'an Wang.

Darshan H. Brahmbhatt, Podcast Editor of JACC: Advances, discusses a recently published original research paper on Sex-Related Differences in Outcomes According to Surgical Treatment Approach in Degenerative Mitral Regurgitation.

#Cardiologia #AfyaCardio #AtualizaçãoMédica Nesse podcast, o Dr. José Roberto fala sobre Como manejar uma insuficiência mitral na emergência Gostou do conteúdo? Compartilhe este vídeo com seus colegas médicos! Aqui você encontra conteúdos atualizados, diretos ao ponto e focados em quem vive a Medicina na prática.

A 17 yo male presents for follow up on a “fainting” episode that occurred during football practice at the end of a running exercise. He states, “I do not know what happened. We finished a set of running sprints and next thing I knew, I was on the ground.” He denies injury from the event and history of prior episodes. His physical examination reveals a crescendo-decrescendo systolic murmur heart best at the apex, increasing in intensity with position change from supine to standing position.  This most likely represents: A. Mitral regurgitation B. Physiologic murmur C. Hypertrophic cardiomyopathyD. Aortic stenosis Visit fhea.com to learn more!

Estenose Mitral descompensada, como manejar? by Cardiopapers

When an unexpected heart murmur shows up, you may not have a specialist on speed dial, but you can have their advice in your back pocket. In this episode of the Partner Podcast, cardiologists John Bonagura and Theresa DeFrancesco share real-world advice on how to detect, stage, and manage myxomatous mitral valve disease. Listen in for practical strategies to deploy the next time you're faced with the unexpected on the other end of the stethoscope. Sponsored by Boehringer IngelheimContact us:Podcast@instinct.vetWhere to find us:Website: CliniciansBrief.com/PodcastsYouTube: Youtube.com/@clinicians_briefFacebook: Facebook.com/CliniciansBriefLinkedIn: LinkedIn.com/showcase/CliniciansBrief/X: @cliniciansbriefInstagram: @clinicians.brief The Team:Beth Molleson, DVM - HostSarah Pate - Producer & Project Manager, Brief StudioTaylor Argo - Podcast Production & Sound Editing

The Intrepid TMVR system just released 2-year transfemoral EFS outcomes at NY Valves. This discussion provides a deeper dive into what this data means for the Intrepid mitral program and perspectives on the transcatheter landscape.

Darshan H. Brahmbhatt, Podcast Editor of JACC: Advances, discusses a recently published original research paper on Bifid-E Wave: A Novel Doppler Marker of Advanced Mitral Prolapse and Disproportionate Left Ventricular Enlargement.

In this episode of the Family Pet Podcast, hosts Michael and Stephen Shirley interview veterinary cardiologist Dr. Eric Owens, Cardiology DVM | DACVIM. They discuss various aspects of pet heart health. They explore common heart diseases in pets, including mitral valve disease in small dogs and dilated cardiomyopathy in large breeds. Dr. Owens shares insights on surgical interventions, the importance of early detection, and tips for maintaining heart health in pets. The conversation also touches on the emotional aspects of heart health, including the phenomenon of broken heart syndrome in humans.Keywordspet health, veterinary cardiology, heart disease, pet care, pet surgery, mitral valve disease, dilated cardiomyopathy, hypertrophic cardiomyopathy, pet heart health, veterinary specialistTakeawaysThe more you know about pet healthcare, the better pet parent you can be.Pet Heart Month is celebrated in February.Common cardiac surgeries are often performed on young dogs with congenital heart diseases.Without treatment, certain heart conditions can be fatal for pets.Mitral valve disease is the most common heart disease in small dogs.Dilated cardiomyopathy primarily affects large and giant breed dogs.Hypertrophic cardiomyopathy is a significant concern in cats.Monitoring breathing and signs of distress is crucial for pet heart health.Early detection of heart disease can lead to better outcomes for pets.Broken heart syndrome in humans is known as Takotsubo cardiomyopathy.

Send us a textSt. Luke's cardiologist Dr. Nidhi Madan joins Dr. Arnold on today's episode to discuss mitral valve conditions and how they are treated with MitraClip. To learn more about heart care services at St. Luke's, visit unitypoint.org/cr-heart.Do you have a question about a trending medical topic? Ask Dr. Arnold! Submit your question and it may be answered by Dr. Arnold on the podcast! Submit your questions at: https://www.unitypoint.org/cedarrapids/submit-a-question-for-the-mailbag.aspxIf you have a topic you'd like Dr. Arnold to discuss with a guest on the podcast, shoot us an email at stlukescr@unitypoint.org.

Message our hosts, Kieran and Jose.Season 3 of The Animal Heartbeat is all about the Veterinary Cardiology Icons - those who walk among us as legends of the veterinary cardiology world.This episode features Professor Chris Orton of Colorado State University. Prof Orton has been a leader in the field of canine heart surgery for over thirty years, having worked to develop both open heart surgery techniques on cardiopulmonary bypass and minimally invasive techniques to treat valve disease. Chris is known as a cardiologist and a surgeon, but also has a strong bench-top research background, evaluating the mitral valve and the mechanisms of degenerative disease.Join our hosts, Jose and Kieran, as they discuss Prof Orton's research experience and his experience over the last 3-years of trans-catheter edge-to-edge mitral valve repair, patient considerations and outcomes.

Challenges to Develop a Mitral Replacement Program

This week on The Beat, CTSNet Editor-in-Chief Joel Dunning speaks with Dr. David Kalfa, the incoming Chief of Pediatric Cardiac Surgery and Co-Director of the Heart Institute at Nicklaus Children's Hospital in Miami, about allogeneic mitral valve transplants. Chapters 00:00 Intro 01:46 Interview Preview 02:54 MV Surgery After Failed Intervention 07:46 Tears Predict Outcomes After Hemi-Arch 10:32 Pain Catastrophizing Scale 14:27 ARR w Stentless Biopros, Sex Difference 16:38 Open Implant TAV via Redo Sternotomy 19:05 Repeat Sternotomy w Completion Unifocaliz 21:07 Direct Aortic Impella 5.5 in PC Shock 25:16 Dr. Kalfa Interview, AMV Transplant 39:58 Upcoming Events 41:26 Closing They discuss methods for obtaining a mitral valve for transplantation, and topics such as immunosuppression, aortic coagulation, and the progress that has been made in this field. They also explore how to perform a living allogeneic heart valve transplant and the future of this technique.   Joel also highlights recent JANS articles on mitral valve surgery after failed transcatheter intervention for mitral regurgitation, whether distal anastomotic new entry tears predict long-term outcomes after hemiarch repair for DeBakey I aortic dissection, using a pain catastrophizing scale as a predictor for acute postoperative pain following video-assisted thoracoscopic surgery lobectomy, and sex difference in aortic root replacement with a stentless bioprosthesis.  In addition, Joel explores an open implantation of a transcatheter aortic valve via redo sternotomy, mitral valve replacement, and tricuspid valve repair in a high-risk patient, repeat sternotomy with completion unifocalization and extensive pulmonary arterial reconstruction in ToF/PA/MAPCAs, and direct aortic Impella 5.5 in post-cardiotomy shock. Before closing, Joel highlights upcoming events in CT surgery.    JANS Items Mentioned  1.) Mitral Valve Surgery After Failed Transcatheter Intervention for Mitral Regurgitation: Techniques, Challenges, and Outcomes  2.) Distal Anastomotic New Entry Tears Predict Long-Term Outcomes After Hemi-Arch Repair for DeBakey I Aortic Dissection  3.) Pain Catastrophizing Scale as a Predictor for Acute Postoperative Pain Following Video-Assisted Thoracoscopic Surgery Lobectomy  4.) Sex Difference in Aortic Root Replacement With a Stentless Bioprosthesis  CTSNET Content Mentioned  1.) Open Implantation of a Transcatheter Aortic Valve via Redo Sternotomy, Mitral Valve Replacement, and Tricuspid Valve Repair in a High-Risk-Patient  2.) Challenging Pulmonary Arterial Reconstruction: Repeat Sternotomy With Completion Unifocalization and Extensive Pulmonary Arterial Reconstruction in ToF/PA/MAPCAs   3.) Direct Aortic Impella 5.5 in Post-Cardiotomy Shock  Other Items Mentioned  1.) Allogeneic Mitral Valve Transplant: Historical Precedent, Current Considerations, and Future Implementation  2.) Cardiac Surgical Arrest—An International Conversation, Part 1  3.) Winners of the 2025 CTSNet Instructional Video Competition  4.) Career Center   5.) CTSNet Events Calendar  Disclaimer The information and views presented on CTSNet.org represent the views of the authors and contributors of the material and not of CTSNet. Please review our full disclaimer page here.

1. Longer-term Outcomes with AMEND Mitral Annuloplasty: First-in-Human Cohort 2. Evaluating The Safety Profile Of Transcatheter Tricuspid Valve Repair: Insights From The Triluminate Pivotal Study Of

In this episode, Dr. Valentin Fuster dives into the complex and high-stakes world of cardiogenic shock, spotlighting new clinical trials, expert consensus guidance, and cutting-edge insights from machine learning. From evaluating the impact of intra-aortic balloon pumps to rethinking mechanical support strategies, the episode delivers a powerful update on one of cardiology's most urgent challenges.

In this episode, Dr. Valentin Fuster dives into the complex and high-stakes world of cardiogenic shock, spotlighting new clinical trials, expert consensus guidance, and cutting-edge insights from machine learning. From evaluating the impact of intra-aortic balloon pumps to rethinking mechanical support strategies, the episode delivers a powerful update on one of cardiology's most urgent challenges.

Insuficiência mitral na IC: quando o MitraClip faz a diferença? by Cardiopapers

This special issue of JACC is dedicated to the essential role of cardiovascular surgery in advancing modern cardiology.

A 27-year-old woman presents as a new patient to your practice.  She is without chief complaint. She asks to, “get a refill on my birth control pills” , having used combined oral contraceptives for the past 12 years without adverse effects.  Social history reveals she is a nonsmoker, without recreational drug use, drinks approximately 1-2 mixed drinks per week, and runs 2-3 miles 5 days a week with reported excellent activity tolerance. Her health history is generally unremarkable, but with patient report of a “mild heart murmur that was picked up when I was a teenager during a physical I needed so I could run track. I was told not to worry about it.” Physical exam is unremarkable with the exception of a mid-systolic click followed by a grade II mid to late systolic murmur without radiation. The remainder of the cardiac exam is within normal limits.  These findings most likely represent which type of murmur? A. PhysiologicB. Aortic stenosis C. Mitral regurgitation D. Mitral valve prolapse---YouTube: https://www.youtube.com/watch?v=wmGI7v_DPMY&list=PLf0PFEPBXfq592b5zCthlxSNIEM-H-EtD&index=105Visit fhea.com to learn more!

Hey Heart Buddies! Boots Knighton speaks with Lucinda McDermott about navigating heart health after discovering a severely leaking tricuspid valve. Lucinda shares her journey, from initial chest pain and fainting to being diagnosed with a heart murmur by her OB GYN. After mitral valve replacement in 2017, Lucinda faced additional challenges, including fragmented healthcare and dismissive cardiologists. Both Lucinda and Boots stress the importance of patient advocacy, support networks like WomenHeart, and having a “heart doula” during medical appointments. The episode highlights key issues like secure insurance, patient empowerment, and the significance of clear communication with healthcare providers.Want to contact Lucinda? Email her: lucimc2319@gmail.comJoin the Newsletter for almost weekly content for this podcast and other heart related news.Join the Patreon Community! The Joyful Beat zoom group is where you'll find connection and hope that you aren't alone in your journey.If you just want to support the show as a one-time gift (thank you), go here.**I am not a doctor and this is not medical advice. Be sure to check in with your care team about all the next right steps for you and your heart.**How to connect with BootsEmail: Boots@theheartchamberpodcast.comInstagram: @openheartsurgerywithboots or @boots.knightonLinkedIn: linkedin.com/in/boots-knightonBoots KnightonIf you enjoyed this episode, take a minute and share it with someone you know who will find value in it as well. You can share directly from this platform or send them to:Open Heart Surgery with Boots Mentioned in this episode:Heart Valve Voice - USBe sure to check out HHV - US!HVV-US

As we step away for a holiday break, we're excited to revisit some of the most popular episodes of the FNP Certification Q & A Podcast. These listener favorites have informed, inspired, and empowered aspiring NPs on their journey to certification success. Enjoy some of our favorites. We'll catch you in 2025 with fresh questions from Dr. Fitzgerald!In evaluating a 66-year-old man with dilated cardiomyopathy and heart failure, the NP notes a grade 3/6 medium-pitched blowing systolic murmur that radiates to the axillae. What do these findings most likely represent?A.Innocent murmurB. Mitral stenosisC. Aortic regurgitationD. Mitral regurgitation---YouTube: https://www.youtube.com/watch?v=jhrYmC-kq6Y&list=PLf0PFEPBXfq592b5zCthlxSNIEM-H-EtD&index=102Visit fhea.com to learn more!

In today's VETgirl online veterinary CE podcast, we're going to talk about one of my favorite breeds, the super sweet Cavalier King Charles Spaniel (what we'll Cavaliers from now on, since it's a mouthful!). Unfortunately, we all know that this breed has horrible myxomatous mitral valve disease. So, if you see Cavaliers in your clinic, when should you decide to put these dogs on heart medications? After all, we know that the initiation of pimobendan can significantly delay the onset of congestive heart failure in dogs with stage B2 myxomatous mitral valve disease (or “mitral valve disease”), and that detection of the transition from stage B1 to B2 in this population of dogs is important so that therapy can be initiated expediently.Sponsored By: Antech